March 20, 2025 - 10:26

Avalo Therapeutics has announced its financial results for 2024, highlighting significant updates regarding its ongoing clinical trials and organizational changes. The company is eagerly anticipating topline data from the Phase 2 LOTUS Trial of AVTX-009, which is being investigated for the treatment of hidradenitis suppurativa. This crucial data is expected to be released in 2026, marking an important milestone in Avalo's research and development efforts.
In a strategic move to bolster its leadership team, Avalo has appointed Jennifer Riley as the Chief Strategy Officer. Her expertise is expected to enhance the company's strategic direction as it navigates the complex landscape of biotechnology.
As of December 31, 2024, Avalo reported having approximately $135 million in cash reserves. This financial position is projected to provide sufficient runway into at least 2027, allowing the company to continue its focus on advancing innovative treatments for immune dysregulation.
November 19, 2026 - 01:19
Skydance Unveils New Marketing Leadership Team Following Recent DealSkydance has announced its new marketing leadership team in the wake of the recent Paramount-WBD deal. In a memo from marketing chief Rebecca Mall, the company outlined the strategic direction and...
November 18, 2026 - 06:53
Executives Worry About Democratic Control in TexasA wave of concern has swept through Texas business circles as executives grapple with the implications of a potential Democratic takeover of the state`s executive branch. Many industry leaders fear...
November 17, 2026 - 20:26
Nvidia Posts Quarterly Earnings Amid Leadership ChangesNvidia released its first quarterly earnings report since Jensen Huang stepped down as CEO last week amid allegations of extramarital affairs. The earnings report revealed a mixed bag of results,...
November 17, 2026 - 02:27
Mastering the Algorithm: Key Insights for Business LeadersIn today`s fast-paced market, consumers are still the focal point for consumer packaged goods and retail brands. However, they are increasingly sharing the spotlight with algorithms. As artificial...